Click For Photo: https://i.dailymail.co.uk/1s/2019/04/04/17/11229286-0-In_the_letters_the_US_Food_and_Drug_Administration_reprimanded_M-a-37_1554393791323.jpg
French health officials have officially banned two types of breast implants because of fears they can cause cancer.
Surgeons in the country will no longer be allowed to use implants with a textured or polyurethane-coated surface.
Country - National - Agency - Medicines - Health
The country's National Agency of Medicines and Health Products (ANSM) made the announcement today, reporting that 59 cases of implant-caused cancer have been confirmed since 2011.
It said there is a 'rare but serious danger' of women developing anaplastic large cell lymphoma as a result of their implants.
Move - Ban - Year - Safety - Approval
The move follows a de facto ban by the French last year when they refused to renew the safety approval of certain implants made by the company Allergan.
Health chiefs are growing increasingly concerned about a link between implants and anaplastic large cell lymphoma (BIA-ALCL).
Illness - Type - Lymphoma - Blood - Cells
The illness is a rare type of non-Hodgkin lymphoma and occurs when white blood cells turn cancerous and build up in the lymph nodes – immune system reservoirs.
French news publication Le Monde, which published a leaked letter the ANSM sent to implant manufacturers, called the decision 'historic'.
ANSM - Companies - BIA-ALCL - Cancer - Pathology
The ANSM reportedly told the companies BIA-ALCL has a 'rare cancer pathology, but [is] likely to lead to the death of patients'.
The government organisation has been tracking people with the breast implants since 2011, when concerns about the link to cancer were first raised.
BIA-ALCL - ANSM - Women - Implants
And among those who developed BIA-ALCL, the ANSM said women with textured implants were 'over-represented'.
Around 400,000 women in France are believed to have breast implants, but the ANSM today said there was no need for them to have them removed in light of the ban.
Move - Implants - Market
It described the move as 'precautionary' and it will result in the implants concerned being removed from the French market.
In its statement the ANSM said: 'Given the rarity of the risk of occurrence of [cancer], the ANSM does not recommend preventive...
Wake Up To Breaking News!